One antiplatelet drug after heart valve replacement

(Loyola University Health System) Treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots. A Loyola Medicine study has found that a single antiplatelet drug may work just as well, with lower risks of life-threatening bleeding and other complications.